Bank of America is now forecasting three Federal Reserve rate hikes totaling 75 basis points before the end of the year - September, October, and December - which would push the policy rate to 4.25-4.5%. The trigger is an inflation problem that has gotten measurably worse: CPI climbed to 3.8% in May, a three-year high, driven in part by energy prices tied to the war with Iran, with core PCE potentially reaching 3.5% by mid-year. For cannabis businesses operating on thin margins, in a sector that already faces restricted access to conventional credit, a sustained high-rate environment is not an abstract macroeconomic story - it is an operational pressure with a direct line to the balance sheet.
The cannabis industry has never had a normal relationship with capital markets. Most licensed operators - dispensaries, cultivators, processors, delivery services - cannot access standard commercial banking on the terms that mainstream retailers take for granted. Many still rely on high-cost private debt, hard-money real estate loans, or cannabis-specific lenders that price risk aggressively precisely because federal illegality creates a compliance burden for any institution that touches the sector. Operators running a dispensary point of sale alaska system or a multi-location retail footprint in other regulated states are already paying a premium for capital - and when the Fed tightens, those lenders raise their floors right alongside the broader market, leaving cannabis borrowers with even less room to maneuver.
Here's the catch. Because Treasury yields rise with inflation expectations, and mortgage rates track the 10-year Treasury yield plus a risk premium, the cost of real estate - one of the largest fixed expenses for any dispensary operator - goes up in tandem with the cost of debt. Federal interest payments now exceed combined spending on Medicaid, national defense, and all nondefense discretionary programs, a structural pressure that keeps long-term borrowing costs elevated regardless of where short-term policy rates settle. For cannabis retailers locked into lease renewals or operators trying to finance new buildouts, that dynamic compounds an already difficult financing picture.
What the Rate Path Means for Cannabis Business Finance
Bank of America's economics team frames the hike cycle around new Fed Chair Kevin Warsh's limited options. Core PCE running nearly 70 basis points higher than a year ago, housing-driven disinflation largely exhausted, and sticky core services inflation mean the Fed is losing patience. The bank's base case is that rates stay elevated through next year, with inflation remaining sticky enough to keep the real policy rate from turning restrictive. For cannabis operators, "higher for longer" is the operative phrase - and it matters more to this sector than to almost any other in retail.
The mechanism is straightforward. Rising rates increase the cost of any variable-rate debt already on the books. They raise the hurdle rate for new capital investment, meaning expansion plans - new retail licenses, facility upgrades, vertical integration acquisitions - require higher projected returns to justify the financing cost. They also compress valuations in the cannabis M&A market, where deals are typically structured with significant debt components. Multi-state operators that were already carrying leveraged balance sheets from the 2021-2023 expansion era face the tightest squeeze.
Sectors That Tend to Hold Up - and the Cannabis Parallel
In conventional equity markets, four sectors historically outperform when rates rise: financials, energy, healthcare, and consumer staples. The logic behind consumer staples is the most directly relevant to cannabis retail. Staples companies - businesses selling essential, recurring-purchase products - maintain stable revenues because demand does not erode sharply in inflationary periods. Consumers continue buying. That pricing-power argument applies, with important caveats, to adult-use cannabis retail in mature markets. Where consumers have made cannabis a routine purchase, demand tends to be relatively inelastic. The problem is that "relatively inelastic demand" does not help a dispensary operator whose cost of debt has risen 75 basis points while wholesale flower prices remain compressed and excise tax obligations stay fixed.
The energy parallel is also worth watching. A primary driver of the current inflation spike is the energy shock from the Iran conflict. Elevated energy prices feed directly into cannabis cultivation costs - lighting, HVAC, water heating, and CO₂ supplementation in indoor grows are all energy-intensive. Cultivators operating under tight wholesale pricing pressure cannot easily pass those input cost increases downstream to dispensaries, which in turn face price-sensitive consumers already trading down to value SKUs. The margin gets thinner from both ends.
Practical Implications for Operators
What should licensed cannabis businesses actually do with this forecast? A few things are worth examining now, before September's expected first hike.
- Review any variable-rate debt instruments and model the payment impact of a 75-basis-point increase across the remainder of the year.
- Assess lease structures - particularly any floating-rate or indexed lease provisions on retail or cultivation space - against a scenario where real estate financing costs remain elevated through 2026.
- Examine cash flow from operations with fresh eyes. Dispensaries relying on seed-to-sale compliance systems and POS data should pull inventory turnover, gross margin by SKU, and average transaction value trends. Tighter capital conditions reward operators who know exactly where their margin lives.
- Reconsider expansion timelines that depend on debt financing. The cost of being wrong about a new license buildout is higher when capital is expensive.
Cannabis businesses in states where banking access is improving - thanks to state-chartered programs or credit union participation - are somewhat better positioned. But even those operators face a market where lenders are recalibrating return expectations upward. The fintech and payments layer of cannabis retail faces parallel pressure: cashless payment providers and point-of-sale financing tools in this space often carry their own cost-of-capital exposure, and that gets passed through in fee structures eventually.
To put it plainly: the Fed's inflation problem is the cannabis industry's capital problem. The sector was already operating in a high-cost financing environment by virtue of regulatory structure. A rate cycle that takes the policy rate to 4.25-4.5% and holds it there does not create that problem - it makes an existing one harder to work around.
